0
0
Home » Medical Devices » In Vitro Diagnostics

Bordetella Pertussis Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

The Bordetella pertussis tests market size was valued at $40.7 million in 2021. The Bordetella pertussis tests market research report is built to visualize quantitative market trends within In vitro diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Bordetella Pertussis Tests market for the year 2020 and beyond. Bordetella pertussis, also called whooping cough, is an upper respiratory infectious disease caused by Bordetella pertussis bacteria. The disease spreads person to person by inhaling the tiny droplets of bacteria when an infected person coughs or sneezes.

Bordetella Pertussis Tests Market Size For more insights, download a free report sample

Which are the key regions in the Bordetella pertussis tests market?

The key regions in the Bordetella pertussis tests market are North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa.

Which are the key countries in the Bordetella pertussis tests market?

The key countries in the Bordetella pertussis tests market are Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Egypt, Finland, France, Greece, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Russia, Saudi-Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the UK, UAE, and the US.

Which are the key segments in the Bordetella pertussis tests market?

The key segments in the Bordetella pertussis tests market are Bordetella pertussis Enzyme Immunoassay (EIA) Tests, Bordetella pertussis Multi-parameter NAATs, Bordetella pertussis Other Tests, and Bordetella pertussis, Nucleic Acid Amplification Tests (NAATs). Bordetella pertussis Multi-parameter NAATs has the highest market share.

Bordetella pertussis tests market, by segments

Bordetella pertussis tests market, by segmentsFor more segment insights, download a free report sample

Which are the key companies in the Bordetella pertussis tests market?

The key companies in the Bordetella pertussis tests market are bioMerieux SA, DiaSorin SpA, Luminex Corp, Meridian Bioscience Inc, Quidel Corp, Tecan Group Ltd, PerkinElmer Inc, Hologic Inc, and Qiagen NV.

Bordetella pertussis tests market, by companies

Bordetella pertussis tests market, by companiesTo know more about key companies, download a free report sample

Market report overview

Market size 2021 $40.7 million
Key regions North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa
Key countries Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Egypt, Finland, France, Greece, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Russia, Saudi-Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the UK, UAE, and the US
Key segments Bordetella pertussis Enzyme Immunoassay (EIA) Tests, Bordetella pertussis Multi-parameter NAATs, Bordetella pertussis Other Tests, and Bordetella pertussis Nucleic Acid Amplification Tests (NAATs)
Key companies bioMerieux SA, DiaSorin SpA, Luminex Corp, Meridian Bioscience Inc, Quidel Corp, Tecan Group Ltd, PerkinElmer Inc, Hologic Inc, and Qiagen NV

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have deep understanding of the Bordetella Pertussis Tests market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

  • Understand the impact of COVID-19 on Bordetella Pertussis Tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Bordetella Pertussis Tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Bordetella Pertussis Tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Bordetella Pertussis Tests market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Key Players

Meridian Biosciences

Luminex Corp, Hologic Inc

bioMerieux SA

DiaSorin SpA

Quidel Corp

Tecan Group Ltd

PerkinElmer Inc

Qiagen NV

Frequently Asked Questions

The Bordetella pertussis tests market size was valued at $40.7 million in the year 2021.

The key regions in the Bordetella pertussis tests market are North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa.

The key countries in the Bordetella pertussis tests market are Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Egypt, Finland, France, Greece, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Russia, Saudi-Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the UK, UAE, and the US.

The key segments in the Bordetella pertussis tests market are Bordetella pertussis Enzyme Immunoassay (EIA) Tests, Bordetella pertussis Multi-parameter NAATs, Bordetella pertussis Other Tests, and Bordetella pertussis Nucleic Acid Amplification Tests (NAATs).

The key companies in the Bordetella pertussis tests market are bioMerieux SA, DiaSorin SpA, Luminex Corp, Meridian Bioscience Inc, Quidel Corp, Tecan Group Ltd, PerkinElmer Inc, Hologic Inc, and Qiagen NV.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports